Jared Kaltwasser

On the heels of Winrevair's approval, Gossamer Bio and the Chiesi Group struck a deal to develop seralutinib.

Preliminary data suggest people with Group 1 pulmonary hypertension had improved outcomes if they had ever received hormone replacement therapy.

Research shows health-related quality of life is impacted in major ways by pulmonary arterial hypertension, but a solution to the problem—and the disease itself—has proven elusive.

Healthcare organizations generate and store vast amounts of data but they often have to choose between speed and structure. Data "lakehouses" may be the answer.

The Boomers (1946–1964): Active but aging

The imperative to upgrade healthcare technology infrastructure is clear, but the returns from such investment are anything but.

Hospitals and healthcare software developers are adjusting to a world in which blocking healthcare data will come with potentially stiff penalties under rules proposed by the Office of the National Coordinator for Health Information Technology (ONC).

xCures says artificial intelligence and machine learning can help make sense of disparate medical records.

Mahana’s company’s irritable bowel syndrome digital therapy was the first to digital therapy to gain clearance from the FDA.

Interoperability has been an aspiration in the healthcare IT world for many years. The finalization of new rules means they finally have a chance to prove its merits.

Improving patient monitoring through care-at-home services could help reduce maternal mortality, they say.

Dario is using Sanofi’s research infrastructure to evaluate its digital health products.

However, patients who cannot get insurance coverage will be able to access AspyreRx at a significant self-pay discount.

In two-thirds of published studies, digital therapeutics were found to be cost-effective, and they led to cost savings in most of the other studies. However, most of the research was funded by industry and that might limit its impact.

Feelings of depression and stress are partly to blame for lower fitness levels among people with rheumatoid arthritis.

More than half of participants completed the eight-week course, the authors said.

Big Health CEO Arun Gupta says digital therapeutics companies must "rigorously engage” with payers and focus on broad adoption of their products.

Accountable care organizations (ACOs) use digital health to complement traditional resources.

The study found the pricing for the therapy made it unlikely to be more cost-effective than in-person physical therapy.

Many countries still do not have official frameworks with which to evaluate digital therapies.

The results argue for close clinical management of people with rheumatoid arthritis, say the authors of the meta-analysis that included 14 studies.

Because personal information can be discovered rather easily through ‘reidentification,’ additional steps are needed to protect the privacy of people’s healthcare data.

Manipulating T cells to target cancer cells has worked to treat some cancers. Researchers are investigating whether the same approach might be used to curb the dysregulated immune response that underlies autoimmune disease.

Rates of Graves’ disease, celiac disease, and Sjögren’s syndrome doubled in the United Kingdom between 2000 and 2019.

Existing evidence-evaluation frameworks are not sufficiently targeted toward the specific factors relevant to digital health products, they argue.

Low-to-moderate doses of prednisone appear to lessen rates of nausea and other side effects in patients taking methotrexate, a new study found.

At the start of the pandemic, the government eased rules around prescribing drugs via the internet. Now it is deciding what the permanent rules should be.

The federal government is extending pandemic-era “flexibility” for telehealth prescriptions.

Stimulating PD-1 is a novel approach to treating rheumatoid arthritis, but the strategy could be a fit for other autoimmune diseases.